Brain cancer survival rate is the percentage of people who are alive 5 years after their diagnosis, whether they have few or no symptoms of brain cancer, are free of disease, or are having treatment.

Many countries around the world mark Brain Cancer Awareness month in May. The aim is to raise awareness of the disease, educate people about its symptoms, raise funds for research and empower everyone affected. The brain cancer survival rate indicates the percentage of people with a certain type and stage of brain cancer who survive the disease for a specific period of time after their diagnosis. In most cases, statistics refer to the 5-year brain cancer survival rate.

Symptoms of brain cancer depend on several factors, including the tumor type, size, location and extent, as well as age, health history and more. Some common signs of brain cancer include headache, weakness, numbness, nausea, vomiting or seizures. Some individuals may not feel right cognitively, or have visual, speech or coordination problems. The symptoms may be subtle or develop gradually. Symptoms of brain cancer are influenced by which part of the brain is involved and the functional system it affects (e.g., motor, sensory, language, etc.). For example, vision problems may result from a tumor near the optic nerve. A tumor in the front part of the brain may affect the ability to concentrate and think. A tumor located in an area that controls motor function may cause weakness, numbness or difficulty with speech. Any tumor that is significantly large can create multiple symptoms because of the pressure created by the mass.Symptoms of brain and spinal cord tumors generally develop slowly and worsen over time unless they are treated.

Canada Cancer clinics and hospitals

Cancer Statistics and Survival Rates

Survival rates can be calculated by different methods for different purposes. The brain cancer survival rates presented based on the relative survival rate. The relative survival rate measures the survival of patients with brain cancer in comparison to the general population to estimate the effect of cancer. Half of people with lung cancer die within six months of diagnosis, says a report from Macmillan Cancer Support which looked at variations in cancer survival rates. While breast cancer and prostate cancer have a five-year survival rate of more than 80%, lung cancer’s is around 10%.Those who survive lung cancer for five years are then 10 times more likely to get another cancer.Macmillan said improving early diagnosis was key.In their report, the cancer charity carried out an analysis of almost 85,000 cancer patients’ experiences of the NHS in England from 2004 to 2011.

Survival rates are a way for doctors and patients to get a general idea of the outlook (prognosis) for people with a certain type of tumor. Some people want to know the statistics for people in their situation, while others may not find them helpful, or may even not want to know them. Survival rates are based on previous outcomes of large numbers of people who had the disease, but they can’t predict what will happen in any person’s case. The type of tumor is important in estimating a person’s outlook. But many other factors can also affect outlook, such as the location of the tumor and whether it can be removed with surgery, as well as a person’s age and overall health. Even when taking these other factors into account, survival rates are at best rough estimates. Your doctor is your best source of information on this, as he or she is familiar with your situation.

Canadians diagnosed with cancer are generally living longer, Statistics Canada says. Five-year survival rates for several cancers have increased since the early 1990s, a finding Statscan said could be because of earlier diagnosis and improvements in treatment. For example, Statistics Canada said the five-year survival rate for people with non-Hodgkin’s lymphoma rose to 63 per cent for those diagnosed in 2004 to 2006, up from 51 per cent for those diagnosed between 1992 and 1994. The five-year ratio for people with leukemia rose to 54 per cent from 44 per cent while the survival rate nearly doubled for those with liver cancer, to 17 per cent from 9 percent.

Age-standardised incidence rates (ASIR, 1992-2007) and age-standardised mortality rates (ASMR, 1992-2006) for all cancers among children, 0-14 years, Canada.
Median Time Between Consecutive Events to Diagnosis and Initiation of Treatment by Age Group, 1995-2000, Canada
Each year, on average 880 children under the age of 15 are diagnosed with cancer and 150 die from the disease.
Although this makes cancer the second leading cause of death by disease among Canadian children, cancer is still relatively rare in this age group.
Among Canadian children, leukemia is the most commonly occurring type of cancer (33%), followed by brain and nervous system cancers (20%) and lymphomas (11%).
Over the last 30 years childhood cancer survival rates have improved substantially, from 71% in the late 1980s to 82% in the early 2000s; 5-year survival rates have increased for several types of childhood cancers.

United states have different Statistics and survival rates. According to The Central Brain Tumor Registry of the United States, more than 124,000 persons in the United States were living with a diagnosis of primary brain and central nervous system cancer in 2004. In 2012, there will be an estimated 22,910 new cases and 13,700 deaths indicating that brain and CNS cancer is one of the most deadly forms of cancer. The incidence of primary malignant brain cancer has been increasing by about 1.2% each year over the last 30 years. In addition to primary brain and CNS cancer, the NIH estimates that 10-30% of adults with cancer will develop brain metastases. Taking the midpoint of this range and based on an annual incidence of cancer (excluding skin cancers) of 1,596,670, the annual US incidence of brain metastases is approximately 319,334. Brain metastases are commonly diagnosed in patients with melanoma, breast, and lung cancer.

Abroad Brain cancer treatment

Brain cancer treatment

  • The following are statistics from various sources about the survival rate for Brain cancer:
  • 27.3 % of people with brain and other nervous system cancer survive after 5 years in the US 1983-90 (SEER)
  • 32% of white people survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 39% of African American people survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 33% survive 5 years in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)

Childhood Cancer Statistics in US: Each year in the U.S. there are approximately 13,400 children between the ages of birth and 19 years of age who are diagnosed with cancer. About one in 300 boys and one in 333 girls will develop cancer before their 20th birthday. In 1998, about 2500 died of cancer, thus making cancer the most common cause of death by disease for children and adolescents in America.

Look in to australia’s statistics and survial rates. Brain tumours affect adults of all ages. There are almost 1,400 new cases of malignant brain tumours in Australia and many more benign brain tumours that can be just as deadly if the tumour is in a vital area of the brain. More than 1,200 people die each year from malignant and benign brain tumours.Brain cancer is also one of the few cancers which occur in children, with 115 new cases a year among children.

In terms of united kingdom one-, three- and five- year net survival rates (1, 2) were estimated for all cerebral astrocytic tumours diagnosed in residents of Uk between 2001 and 2010. Net survival is an estimate of how survival is affected only by the disease of interest, based on the probability of survival of a person with cancer when compared with people of the same age and sex in the whole population of England. The prognosis for cerebral astrocytic tumours is highly dependent on their grade, with survival being extremely poor for WHO grade IV Glioblastomas. However, long term survival for WHO grade 1 tumours is very much better and probably around 90% of these tumours are effectively cured by surgery.